Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Parkinson's disease home diary: further validation and implications for clinical trials.

Hauser RA, Deckers F, Lehert P.

Mov Disord. 2004 Dec;19(12):1409-13.

PMID:
15390057
2.

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.

Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O'Brien CF, Molho ES, Factor SA.

Clin Neuropharmacol. 2000 Mar-Apr;23(2):75-81.

PMID:
10803796
3.

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.

Mov Disord. 2005 Sep;20(9):1205-9.

PMID:
15954135
4.

Electronic motor function diary for patients with Parkinson's disease: a feasibility study.

Lyons KE, Pahwa R.

Parkinsonism Relat Disord. 2007 Jul;13(5):304-7. Epub 2006 Aug 22.

PMID:
16920380
5.

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.

Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H.

Mov Disord. 2007 Jan 15;22(2):179-86.

PMID:
17094088
6.
7.

Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.

Hauser RA, Russ H, Haeger DA, Bruguiere-Fontenille M, Müller T, Wenning GK.

Clin Neuropharmacol. 2006 Nov-Dec;29(6):322-30.

PMID:
17095895
8.

Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments.

Metman LV, Myre B, Verwey N, Hassin-Baer S, Arzbaecher J, Sierens D, Bakay R.

Mov Disord. 2004 Sep;19(9):1079-1084.

PMID:
15372601
9.

High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.

Parkinsonism Relat Disord. 2005 Sep;11(6):393-8.

PMID:
15993640
10.

Activity-based diary for Parkinson's disease.

Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, van Hilten JB.

Clin Neuropharmacol. 2002 Jan-Feb;25(1):43-50.

PMID:
11852296
12.

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM; 6002-US-005 Study Group.

Ann Neurol. 2008 Mar;63(3):295-302. doi: 10.1002/ana.21315.

PMID:
18306243
13.

Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.

Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A.

Mov Disord. 2008 Jul 30;23(10):1479-82. doi: 10.1002/mds.22127.

PMID:
18512751
14.

[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].

Jost WH, Klasser M, Reichmann H.

Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2. German.

PMID:
18833504
15.
16.
17.

Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.

Luo N, Low S, Lau PN, Au WL, Tan LC.

Ann Acad Med Singapore. 2009 Jun;38(6):521-8.

18.

Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental method.

Burkhard PR, Shale H, Langston JW, Tetrud JW.

Mov Disord. 1999 Sep;14(5):754-63.

PMID:
10495036
19.

International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR.

Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.

PMID:
19901251
20.

Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.

Jankovic J.

Mov Disord. 2005;20 Suppl 11:S11-6. Review.

PMID:
15822109

Supplemental Content

Support Center